Randomized trial: Quitline specialist training in gain-framed vs standard-care messages for smoking cessation

Journal of the National Cancer Institute

Volumn 102, Issue 2, 2010, Pages 96-106

  Toll, Benjamin A ^a,b   Martino, Steve ^a   Latimer, Amy ^c   Salovey, Peter ^b,d   O'Malley, Stephanie ^a,b   Carlin Menter, Shannon ^e   Hopkins, Jessica ^a   Wu, Ran ^a   Celestino, Paula ^e   Cummings, K Michael ^e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

^c QUEEN S UNIVERSITY   (Canada)

^d YALE UNIVERSITY   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; EVALUATION; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; NORMAL HUMAN; OUTCOME ASSESSMENT; PERSUASIVE COMMUNICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; STANDARD; UNITED STATES;

ADULT; COMBINED MODALITY THERAPY; DIRECTIVE COUNSELING; EDUCATIONAL STATUS; FEMALE; HEALTH EDUCATION; HOTLINES; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PROGRAM EVALUATION; SMOKING; SMOKING CESSATION; TELEPHONE; TREATMENT OUTCOME; UNITED STATES;

EID: 75149114632     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp468     Document Type: Article

References (59)

1. US Department of Health and Human Services. Cancer Facts & Figures 2008. Atlanta, GA: American Cancer Society 2008.
2. US Department of Health and Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress: A Report of the Surgeon General: 1989 Executive Summary. Rockville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Offi ce on Smoking and Health; 1989.
3. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004; 291 (10): 1238-1245
4. US Department of Health and Human Services. The Health Benefi ts of Smoking Cessation. Rockville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Offi ce on Smoking and Health; 1990
5. National Center for Health Statistics. Health, United States, 2006, With Chartbook With Trends in the Health of Americans. Hyattsville, MD: Public Health Service; 2006.
6. Centers for Disease Control and Prevention. Cigarette smoking among adults-United States, 2004. Morb Mortal Wkly Rep 2005;54 (44) 1121-1124
7. Cummins S, Bailey L, Campbell S, Koon-Kirby C, Zhu S-H. Tobacco cessation quitlines in North America: a descriptive study. Tob Control. 2007; 16 (suppl I): i9-i15.
8. Centers for Disease Control. Best Practices for Comprehensive Tobacco Control Programs. Atlanta, GA: USDHHS 2007.
9. Swartz SS, Cowan TM, Klayman JE, Welton M, Leonard BA. Use and effectiveness of tobacco telephone counseling and nicotine therapy in Maine. Am J Prev Med. 2005; 29 (4): 288-294.
10. Cummins H, Anderson KK, Mills C, Zhu J. Reaching young adult smokers through quitlines. Am J Public Health. 2007; 97 (8): 1402-1405
11. An L, Schillo B, Kavanaugh A, et al. Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy. Tob Control. 2006; 15 (4): 286-293.
12. Hollis J, McAfee T, Fellows J, Zbikowski S, Stark M, Riedlinger K. The effectiveness and cost effectiveness of telephone counseling and the nicotine patch in a state tobacco quitline. Tob Control. 2007; 16 (Suppl 1): i53-i59.
13. Zhu S-H, Anderson C, Tedeschi G, et al. Evidence of real-world effectiveness of a telephone quitline for smokers. N Engl J Med. 2002; 347 (14): 1087-1093.
14. Borland R, Segan C, Livingston P, Owen N. The effectiveness of callback counseling for smoking cessation: a randomized trial. Addiction. 2001; 96 (6): 881-889.
15. Gilbert H, Sutton S. Evaluating the effectiveness of proactive telephone counseling for smoking cessation in a randomized controlled trial. Addiction. 2006; 101 (4): 590-598.
16. Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science. 1981; 211 (4481): 453-458.
17. Rothman AJ, Bartels RD, Wlaschin J, Salovey P. The strategic use of gain-and loss-framed messages to promote healthy behavior: how theory can inform practice. J Commun. 2006; 56 (Suppl 1): S202-S220.
18. Rothman AJ, Salovey P, Antone C, Keough K, Martin CD. The infl uence of message framing on intentions to perform health behaviors. J Exp Soc Psychol. 1993; 29 (5): 408-433.
19. Apanovitch AM, McCarthy D, Salovey D. Using message framing to motivate HIV testing among low income, ethnic minority women. Health Psychol. 2003; 22 (1): 60-67.
20. Mann T, Sherman D, Updegraff J. Dispositional motivations and message framing: a test of the congruency hypothesis in college students. Health Psychol. 2004; 23 (3): 330-334.
21. Rothman AJ, Salovey P. Shaping perceptions to motivate healthy behavior: the role of message framing. Psychol Bull. 1997; 121 (1): 3-19.
22. Banks SM, Salovey P, Greener S, et al. The effects of message framing on mammography utilization. Health Psychol. 1995; 14 (2): 178-184.
23. Schneider TR, Salovey P, Apanovitch AM, et al. The effects of message framing and ethnic targeting on mammography use among low-income women. Health Psychol. 2001; 20 (4): 256-266.
24. Detweiler JB, Bedell BT, Salovey P, Pronin E, Rothman AJ. Message framing and sunscreen use: gain-framed messages motivate beach goers. Health Psychol. 1999; 18 (2): 189-196.
25. Toll B, O'Malley S, Katulak N, et al. Comparing gain-and loss-framed messages for smoking cessation with bupropion: a randomized controlled trial. Psychol Addict Behav. 2007; 21 (4): 534-544.
26. Schneider TR, Salovey P, Pallonen U, Mundorf N, Smith NF, Steward WT. Visual and auditory message framing effects on tobacco smoking. J Appl Soc Psychol. 2001; 31 (4): 667-682.
27. McKee S, O'Malley S, Steward W, Neveu S, Land M, Salovey P. How to word effective messages about smoking and oral health: emphasize the benefi ts of quitting. J Dent Educ. 2004; 68 (5): 569-573.
28. Steward WT, Schneider TR, Pizarro J, Salovey P. Need for cognition moderates responses to framed smoking-cessation messages. J Appl Soc Psychol. 2003; 33 (12): 2439-2464.
29. Latimer A, Green K, Schmid K, et al. The identifi cation of framed messages in the New York State Smokers ' Quitline materials and coaching. Health Educ Res. 2009; doi: 10.1093/her/cyp041.
30. Carroll K, Nich C, Sifry R, et al. A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend. 2000; 57 (1): 225-238.
31. Shrout P, Fleiss J. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979; 86 (2): 420-428.
32. Gonzales D, Rennard S, Nides M, et al. Varenicline, an alpha-4-beta-2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006; 296 (1): 47-55.
33. Jorenby D, Hays J, Rigotti N, et al. Effi cacy of varenicline, an alpha-4-beta-2 nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006; 296 (11): 56-63.
34. Ahluwalia JS, Harris KJ, Catley D, Okuyemi KS, Mayo MS. Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. JAMA. 2002; 288 (4): 468-474.
35. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997; 337 (17): 1195-1202.
36. Cummings K, Hyland A, Fix B, et al. Free nicotine patch giveaway program: 12 month follow-up of participants. Am J Prev Med. 2006; 31 (2): 181-184.
37. Jolicoeur D, Ahluwalia J, Richter K, et al. The use of nicotine patches with minimal intervention. Prev Med. 2000; 30 (6): 504-512.
38. Mckee S, O'Malley S, Salovey P, Krishnan-Sarin K, Mazure C. Perceived risks and benefi ts of smoking cessation: gender-specifi c predictors of motivation and treatment outcome. Addict Behav. 2005; 30 (3): 423-435.
39. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc; 1988.
40. Kline R. Principles and Practice of Structural Equation Modeling. 2nd ed. New York, NY: The Guilford Press; 2005.
41. Hays J, Hurt R, Rigotti N, et al. Sustained-release bupropion for pharma-cologic relapse prevention after smoking cessation: a randomized controlled trial. Ann Intern Med. 2001; 135 (6): 423-433.
42. Swan GE, McAfee T, Curry SJ, et al. Effectiveness of bupropion sustained release for smoking cessation in a health care setting. Arch Intern Med. 2003; 163 (2): 2337-2344.
43. Carroll K, Ball S, Nich C, et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend. 2006; 81 (3): 301-312.
44. Martino S, Carroll K, Nich C, Rounsaville B. A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders. Addiction. 2006; 101 (10): 1479-1492.
45. Martino S, Ball S, Nich C, Frankforter T, Carroll K. Community program therapist adherence and competence in motivational enhancement therapy. Drug Alcohol Depend. 2008; 96 (1-2): 37-48.
46. Latimer A, Rench T, Rivers S, et al. Promoting participation in physical activity using framed messages: an application of prospect theory. Br J Health Psychol. 2008; 13 (pt 4): 659-681.
47. Sobell LC, Sobell MB. Alcohol consumption measures. In: Allen JP, Wilson VB, eds. Assessing Alcohol Problems: A Guide for Clinicians and Researchers. 2nd ed. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003: 75-99.
48. Carroll K, Ball S, Martino S, et al. Computer-assisted delivery of cognitive-behavioral therapy for addiction: a randomized trial of CBT4CBT. Am J Addict. 2008; 165 (5): 881-888.
49. Obermayer J, Riley W, Asif O, Jean-Mary J. College smoking-cessation using cell phone text messaging. J Am Coll Health. 2004; 53 (2): 71-78.
50. Rodgers A, Corbett T, Bramley D, et al. Do u smoke after txt? Results of a randomized trial of smoking cessation using mobile phone text messaging. Tob Control. 2005; 14 (4): 255-261. (Pubitemid 41128902)
51. Reid R, Pipe A, Quinlan B, Oda J. Interactive voice response telephony to promote smoking cessation in patients with heart disease: a pilot study. Patient Educ Couns. 2007; 66 (3): 319-326.
52. Brendryen H, Kraft P. Happy Ending: a randomized controlled trial of digital multi-media smoking cessation intervention. Addiction. 2008; 103 (3): 478-484.
53. Amodei N, Lamb R. Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced. Psychol Addict Behav. 2008; 22 (4): 472-485.
54. Fiore M, Jaén C, Baker T, et al. Treating Tobacco Use and Dependence 2008 Update: Clinical Practice Guideline. Rockville, MD: USDHHS; 2008.
55. Pan W. Proactive telephone counseling as an adjunct to minimal intervention for smoking cessation: a meta-analysis. Health Educ Res. 2006; 21 (3): 416-427.
56. West R. The clinical signifi cance of "small" effects of smoking cessation treatments [editorial]. Addiction. 2007; 102 (4): 506-509.
57. Cummings K, Fix B, Celestino P, Carlin-Menter S, O'Connor R, Hyland A. Reach, effi cacy, and cost-effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract. 2006; 12 (1): 37-43.
58. Miller N, Frieden T, Liu S, et al. Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet. 2005; 365 (9474): 1849-1854.
59. Hays J, Hurt R, Rigotti N, et al. Sustained-release bupropion for pharma-cologic relapse prevention after smoking cessation: a randomized controlled trial. Ann Intern Med. 2001; 135 (6): 423-433.